These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 12431494

  • 21. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR.
    Am J Respir Crit Care Med; 2007 Mar 01; 175(5):507-13. PubMed ID: 17158279
    [Abstract] [Full Text] [Related]

  • 22. The Impact of Alemtuzumab and Basiliximab Induction on Patient Survival and Time to Bronchiolitis Obliterans Syndrome in Double Lung Transplantation Recipients.
    Furuya Y, Jayarajan SN, Taghavi S, Cordova FC, Patel N, Shiose A, Leotta E, Criner GJ, Guy TS, Wheatley GH, Kaiser LR, Toyoda Y.
    Am J Transplant; 2016 Aug 01; 16(8):2334-41. PubMed ID: 26833657
    [Abstract] [Full Text] [Related]

  • 23. Bronchiolitis obliterans following lung transplantation.
    Al-Githmi I, Batawil N, Shigemura N, Hsin M, Lee TW, He GW, Yim A.
    Eur J Cardiothorac Surg; 2006 Dec 01; 30(6):846-51. PubMed ID: 17055283
    [Abstract] [Full Text] [Related]

  • 24. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA, Hranjec T, Swenson BR, Kozower BD, Jones DR, Ailawadi G, Kron IL, Lau CL.
    Ann Thorac Surg; 2010 May 01; 89(5):1555-62. PubMed ID: 20417777
    [Abstract] [Full Text] [Related]

  • 25. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation.
    Atkins BZ, Petersen RP, Daneshmand MA, Turek JW, Lin SS, Davis RD.
    Ann Thorac Surg; 2010 Nov 01; 90(5):1622-8. PubMed ID: 20971276
    [Abstract] [Full Text] [Related]

  • 26. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
    Chalermskulrat W, Neuringer IP, Schmitz JL, Catellier DJ, Gurka MJ, Randell SH, Aris RM.
    Chest; 2003 Jun 01; 123(6):1825-31. PubMed ID: 12796156
    [Abstract] [Full Text] [Related]

  • 27. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY, Fertel D, Srivastava K, Panos A, Nguyen D, Baxter T, Shafazand S, Pham SM.
    Ann Thorac Surg; 2014 Jan 01; 97(1):268-74. PubMed ID: 24119986
    [Abstract] [Full Text] [Related]

  • 28. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA.
    Am J Respir Crit Care Med; 2008 May 01; 177(9):1033-40. PubMed ID: 18263803
    [Abstract] [Full Text] [Related]

  • 29. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.
    Lama VN, Murray S, Mumford JA, Flaherty KR, Chang A, Toews GB, Peters-Golden M, Martinez FJ.
    Am J Respir Crit Care Med; 2005 Aug 01; 172(3):379-83. PubMed ID: 15894603
    [Abstract] [Full Text] [Related]

  • 30. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG, Gupta MR, Walker JE, Seoane L, Bonvillain RW, Lombard GA, Weill D, Dhillon GS.
    J Heart Lung Transplant; 2009 Feb 01; 28(2):163-9. PubMed ID: 19201342
    [Abstract] [Full Text] [Related]

  • 31. The impact of bronchiolitis obliterans on late morbidity and mortality after single and bilateral lung transplantation for pulmonary hypertension.
    Sundaresan S.
    Semin Thorac Cardiovasc Surg; 1998 Apr 01; 10(2):152-9. PubMed ID: 9620464
    [Abstract] [Full Text] [Related]

  • 32. Assessment of forced expiratory volume in one second-fraction of the engrafted lung with 133-Xe radiospirometry improves the diagnosis of bronchiolitis obliterans syndrome in single lung transplant recipients.
    Ikonen T, Harjula AL, Kinnula VL, Savola J, Sovijärvi A.
    J Heart Lung Transplant; 1995 Apr 01; 14(2):244-50. PubMed ID: 7779842
    [Abstract] [Full Text] [Related]

  • 33. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE, Ruttens D, Vandermeulen E, Vaneylen A, Dupont LJ, Van Raemdonck DE, Verleden GM, Vanaudenaerde BM, Vos R.
    Transplantation; 2013 May 15; 95(9):1167-72. PubMed ID: 23425818
    [Abstract] [Full Text] [Related]

  • 34. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
    Fakhro M, Ingemansson R, Algotsson L, Lindstedt S.
    Ann Transplant; 2017 Sep 05; 22():532-540. PubMed ID: 28871078
    [Abstract] [Full Text] [Related]

  • 35. The impact of cytolytic therapy on bronchiolitis obliterans syndrome.
    Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP.
    J Heart Lung Transplant; 1998 Sep 05; 17(9):869-75. PubMed ID: 9773858
    [Abstract] [Full Text] [Related]

  • 36. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD, Karamichalis J, Robbins RC, Whyte RI, Theodore J, Reitz BA.
    Ann Thorac Surg; 2006 Jan 05; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [Abstract] [Full Text] [Related]

  • 37. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.
    Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ.
    J Heart Lung Transplant; 2010 May 05; 29(5):531-7. PubMed ID: 20133163
    [Abstract] [Full Text] [Related]

  • 38. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.
    Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M.
    J Heart Lung Transplant; 2007 Jul 05; 26(7):681-6. PubMed ID: 17613397
    [Abstract] [Full Text] [Related]

  • 39. Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosis.
    Wille KM, Gaggar A, Hajari AS, Leon KJ, Barney JB, Smith KH, Pajaro O, Wang W, Oster RA, McGiffin DC, Young KR.
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec 05; 25(2):117-24. PubMed ID: 19382530
    [Abstract] [Full Text] [Related]

  • 40. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
    Valentine VG, Robbins RC, Berry GJ, Patel HR, Reichenspurner H, Reitz BA, Theodore J.
    J Heart Lung Transplant; 1996 Apr 05; 15(4):371-83. PubMed ID: 8732596
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.